Andrea Mari

Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients.

D. Bruttomesso, M. Marescotti, A. Avogaro, 1999, Diabetes.

Evidence that vildagliptin attenuates deterioration of glycaemic control during 2‐year treatment of patients with type 2 diabetes and mild hyperglycaemia *

P. Nilsson, W. Scherbaum, A. Mari, 2008, Diabetes, obesity & metabolism.

Efficacy and tolerability of vildagliptin in drug‐naïve patients with type 2 diabetes and mild hyperglycaemia *

W. Scherbaum, A. Mari, J. Foley, 2008, Diabetes, obesity & metabolism.

Glucokinase, the pancreatic glucose sensor, is not the gut glucose sensor

J. Holst, A. Tura, A. Mari, 2008, Diabetologia.

Differential effects of once‐weekly glucagon‐like peptide‐1 receptor agonist dulaglutide and metformin on pancreatic β‐cell and insulin sensitivity during a standardized test meal in patients with type 2 diabetes

B. Ludvik, A. Mari, S. Del Prato, 2016, Diabetes, obesity & metabolism.

Improvement in β-cell function after diet-induced weight loss is associated with decrease in pancreatic polypeptide in subjects with type 2 diabetes.

A. Mari, H. Kahleová, L. Kazdová, 2012, Journal of diabetes and its complications.